On the FDA's permitting of new drugs, economists who actually express a policy judgment (Friedman, Peltzman, Becker, and topic specialists) overwhelmingly favor liberalization, yet randomly surveyed economists are rather supportive of the current FDA—revealing a significant impasse between issue-expressive and random economists.

factualpending

Speaker

Dan Klein

Evidence Quote

“there's a very significant impasse between the issue expressive economists if you will the so-called you might call them specialists”

Source

Dan Klein on Truth, Bias, and Disagreement 03/16/2009— EconTalk
Created: 6/16/2026, 2:03:33 PM

Your notes

Loading notes...